Coruzzi, Laura A. Ph.D.

Current Employment Position(s)

Partner

Lawyer Overview

Laura Coruzzi has represented clients in biotechnology and pharmaceuticals for close to 30 years. Prior to joining Jones Day, she practiced at Pennie & Edmonds LLP and was one of the first members of that firm's biotechnology group founded by S. Leslie Misrock, affectionately known as the "father of biotechnology patent law." Dr. Coruzzi's practice has evolved with the patent laws and matured with the needs of the biotechnology and pharmaceutical industries. Her practice involves all aspects of patent law as it relates to a variety of disciplines in the life sciences, including genetic engineering, molecular biology, virology, vaccines, immunology, therapeutic antibodies, biologic and small molecule therapeutics, diagnostics, drug discovery, and drug delivery.

Dr. Coruzzi's patent procurement practice focuses on strategic planning and management of patent portfolios designed to protect emerging new technologies as well as mature biologic and pharmaceutical therapeutics and diagnostics. She counsels clients on portfolio evaluation, due diligence investigations, patent prosecution and interferences, European oppositions, and licensing. Dr. Coruzzi's practice also encompasses patent litigation and appeals before the USPTO Board of Appeals and the Federal Circuit. Prior to joining Jones Day, she and her team won reversal of an $18 million jury verdict in 2000 for Cadus Pharmaceutical Corporation in a case involving cell-based assays for drug screening.

Dr. Coruzzi is frequently invited to speak at symposia on patent law issues related to life sciences.

Areas of Practice

• Intellectual Property
• Patent Litigation
• Patent Prosecution
• Federal Circuit and IP Appeals
• Life Sciences
• Pharmaceuticals

Representative Cases

• Advanced Tissue Sciences establishes patent portfolio for tissue engineering
• Bristol-Myers Squibb establishes patent portfolio for ddl anti-HIV drug
• Cadus Pharmaceuticals successfully overturns $18M verdict on appeal
• Cell Genesys establishes and protects patent portfolio for gene activation
• Esperion establishes patent portfolios for small molecule cholesterol-lowering drugs
• Genzyme and Mt. Sinai School of Medicine settle patent dispute with Transkaryotic over biological drug for genetic disorder
• Herbalife pursues patent infringement action over dietary supplements , (2009)
• Herbalife successfully defends against patent infringement charge related to managing dynamic web pages
• Human Genome Sciences builds patent portfolio for certain growth factors
• Liposome files patent infringement charges involving drug formulation process
• MedImmune builds patent portfolio for genetically engineered negative strand RNA viruses , (2009)
• Millennium develops patent portfolio for functional genomics drug discovery program
• Mt. Sinai School of Medicine develops patent portfolio for genetically engineered negative strand RNA viruses and biological drugs for the treatment of Fabry's Disease
• Myriad Genetics and Univ. of Utah Research Foundation defend the right to patent genes in landmark case
• Sugen develops patent portfolio for drugs used in cancer treatment
• Trimeris builds patent portfolio for antiviral HIV treatment drug Fuzeon®
• Warren Pharmaceuticals establishes patent portfolio for cytoprotective cytokines, including erythropoietin

West Practice Categories

Copyrights, Federal Appellate Practice, Federal Trial Practice, Intellectual Property Law, International Intellectual Property, Patent Litigation, Patents, State Trial Practice, Technology Licensing, Trade Dress, Trade Secrets, Trademarks, US Court of Appeals for the Federal Circuit, US Supreme Court

Bar Admissions

• New York

Education

• Fordham University

Published Works

• The Crusade for Follow-On Biologics - The Next Wave of Pharmaceutical Patent Litigation?, LANDSLIDE, ABA IP Section Magazine, Vol. 2, No. 1, pp. 30-35, 50, 2009
• Outstanding Women: Laura Coruzzi, IP Law360, 2007
• Jones Day's Intellectual Property Practice, 2006
• Intellectual Property: Petition for Certiorari Filed in AWH Corp. v. Phillips, 2005
• Winning Legal Strategies for Biotech Companies: Intellectual Property Protection, FDA Approval, and Board Management for the Biotech Industry (Inside the Minds), coauthor, Aspatore Books, Legal Strategies for Biotechnology Companies, 2005
• Intellectual Property: The Supreme Court Widens the Range of Permissible Preclinical Studies Under the § 271(e)(1) Safe Harbor For Patent Infringement —But How Much?, 2005

Address

222 East 41st Street
New York, NY 10017-6702

Phones

1.212.326.8383 (Business Phone)

Faxes

1.212.755.7306 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com